Search Results - "Hellwig, Tânia"

Important Role of Early Therapy and Maintaining Uninterrupted Treatment In the Outcomes of Chronic Myelogenous Leukemia Patients Treated with Imatinib by Ottoni, Erica Lammerhirt, Capra, Marcelo, Schaan, Mariza, Schilling, Marco Antônio, Fassina, Katia, Fernandes, Mario Sérgio, Almeida, Denise, Nene, Moema, Hellwig, Tânia, Costa, Tito Vanelli, Zardo, Adriana, Almeida, Andréia Dias, Nachtigal, Gilca, Fraga, Christina G S, Daudt, Liane Esteves, Silla, Lucia, Fogliatto, Laura

“…Abstract 2300 Imatinib mesylate (Gleevec) treatment for Chronic Myelogenous Leukemia (CML) was first introduced in Brazil in 2003, initially used as second…”
Get full text

Impact of Comorbidity In Event-Free Survival, Toxicity and Adherence to Treatment In Chronic Myeloid Leukemia Patients Treated with Imatinib by Fogliatto, Laura, Capra, Marcelo, Schaan, Mariza, Fassina, Katia, Fernandes, Mario Sérgio, Schilling, Marco Antônio, Almeida, Denise, Nene, Moema, Hellwig, Tânia, Nachtigal, Gilca, João, Adriana Zardo, Almeida, Andréia Dias, Costa, Tito Vanelli, Ottoni, Erica Lammerhirt, Fraga, Christina G S, Daudt, Liane Esteves, Silla, Lucia

“…Abstract 2296 Comorbidity in cancer has been shown to be a major determinant in treatment selection and survival. The most used instrument for measuring…”
Get full text

Results of Imatinib Therapy In Patients with Early and Late Chronic-Phase Chronic Myeloid Leukemia In a South Brazilian Cohort by Capra, Marcelo, Shaan, Mariza, Fassina, Katia, Fernandes, Mario Sérgio, Schilling, Marco Antônio, Almeida, Denise, Nene, Moema, Hellwig, Tânia, Nachtigal, Gilca, Zardo, Adriana, Almeida, Andréia Dias, Costa, Tito Vanelli, Ottoni, Erica Lammerhirt, Torriani, Mayde Seadi, Fraga, Christina G S, Daudt, Liane Esteves, Silla, Lucia, Fogliatto, Laura

“…Abstract 4487 Imatinib treatment for Chronic Myeloid Leukemia (CML) was first introduced in Brazil in 2001, initially used as second line therapy for patients…”
Get full text

The Role of Early Cytogenetic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib and the Impact of Adherence and Comorbidities by Fogliatto, Laura, Capra, Marcelo, Shaan, Mariza, Costa, Tito Vanelli, Torriani, Mayde Seadi, Fassina, Katia, Fernandes, Mario Sérgio, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Coser, Virgínia, Pereira, Dalnei Veiga, Pereira, Waldir Veiga, Wisintainer, Sabrina, Daltoe, Tiago, Moschen, Mariangela, Zardo, Adriana, Kratochvil, Juliana, Fernandes, Viviane Magagnin, Eickhoff, Cheila, Ahmad, Saozan, Almeida, Andréia Dias, Nene, Moema, Xavier, Nathália Guterres, Koshiyama, Dayane, Leite, Márcia, Lenz, Vitor, Daudt, Liane Esteves, Silla, Lucia

“…Abstract 4423 Treatment of chronic myeloid leukemia with imatinib leads to disease remission in a majority of patient, but in some patients (pts) controlling…”
Get full text

Determinants and Impact of Treatment Interruptions and Nonadherence to Imatinib Therapy in Patients with Chronic Myeloid Leukemia in a South Brazilian Cohort by Capra, Marcelo, Fogliatto, Laura, Shaan, Mariza, Torriani, Mayde Seadi, Costa, Tito Vanelli, Fernandes, Mario Sérgio, Fassina, Katia, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Coser, Virgínia, Pereira, Dalnei Veiga, Pereira, Waldir Veiga, Moschen, Mariangela, Daltoe, Tiago, Wisintainer, Sabrina, Eickhoff, Cheila, Fernandes, Viviane Magagnin, Kratochvil, Juliana, Ahmad, Saozan, Zardo, Adriana, Almeida, Andréia Dias, Lenz, Vitor, Leite, Márcia, Nene, Moema, Koshiyama, Dayane, Xavier, Nathália Guterres, Daudt, Liane Esteves, Silla, Lucia

“…Abstract 4425 Adherence to imatinib therapy has proven to be a major determinant of treatment results, but the degree of impact and the determinants of…”
Get full text

TKI Treatment Discontinuation: How Many Patients Could Stop Tyrosine Kinase Treatment According to Discontinuation Trials Criteria? Incidence and Prognostic Impact of Deep Molecular Response in a Cohort of Chronic Myeloid Leukemia Patients of South Brazil’s Hematology Centers by Fogliatto, Laura, Capra, Marcelo Eduardo Zanella, Shaan, Mariza, Vanelli Costa, Tito, Contin, Luis Carlos Zanandrea, Breunig, Raquel, Silveira, Juarez Fontoura, Torriani, Mayde Seadi, Fassina, Katia, Fernandes, Mario Sergio, Almeida, Denise, Schilling, Marco Antonio, Hellwig, Tânia, Daltoe, Tiago, Moschen, Mariangela, Zardo, Adriana, Nene, Moema, Daudt, Liane Esteves, Friedrisch, João, Silla, Lucia

“…Sustained deep molecular response (MR4.5) after imatinib treatment defines a subgroup of patients with chronic myeloid leukemia (CML) with better outcome and…”
Get full text

The Impact of Early Molecular Response in Event Free Survival in Patients with Chronic Myeloid Leukemia Treated with Imatinib by Fogliatto, Laura, Capra, Marcelo Eduardo Zanella, Shaan, Mariza, Costa, Tito Vanelli, Torriani, Mayde Seadi, Contin, Luis Carlos Zanandrea, Breunig, Raquel, Fassina, Katia, Fernandes, Mario Sérgio, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Daltoe, Tiago, Zardo, Adriana, Moschen, Mariangela, Nene, Moema, Silveira, Juarez Fontoura, Soares, Tahiane Brum, Daudt, Liane Esteves, Friedrisch, João, Silla, Lucia

“…Background Monitoring response to TKI therapy is one of the key management strategies of chronic myeloid leukemia (CML). Early molecular response to first-line…”
Get full text

Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil by Capra, Marcelo, Vilella, Líbia, Pereira, Waldir Veiga, Coser, Virgínia Maria, Fernandes, Mário Sérgio, Schilling, Marco Antônio, Almeida, Denise, Gross, Mauro, Leite, Márcia, Hellwig, Tânia, Natchigal, Gilca, Zelmanowicz, Alice, Paskulin, Giorgio, Neumann, Jorge, Silla, Lúcia

“…Rio Grande do Sul (RS), in South Brazil, with about 10 million inhabitants, is known for its agricultural activities and consequent increased human exposure to…”
Get full text

Warning As Defiened By European Leukemia Net 2013 (ELN 2013) In Chronic Phase Chronic Myeloid Leukemia (CP-CML) Corresponds To Warning In The Clinical Practice? by Fogliatto, Laura, Capra, Marcelo, Shaan, Mariza, Costa, Tito Vanelli, Breunig, Raquel, Fraga, Christina G S, Torriani, Mayde Seadi, Silla, Lucia, Daudt, Liane Esteves, Fernandes, Mario Sérgio, Almeida, Denise, Schilling, Marco Antônio, Hellwig, Tânia, Fassina, Katia, Wisintainer, Sabrina, Moschen, Mariangela, Daltoe, Tiago, Zardo, Adriana, Kratochvil, Juliana, Fernandes, Viviane Magagnin, Eickhoff, Cheila, Nene, Moema, Ahmad, Saozan, Almeida, Andréia Dias, Lenz, Vitor

“…Treatment of chronic myeloid leukemia with imatinib leads to disease remission in a majority of patients (pts), but in a subgroup of pts controlling the…”
Get full text

Obinutuzumab for CLL Relapsed and Refractory Patients When New Oral Drugs an Not Available by Fogliatto, Laura, Grokoski, Kamila, Segatto, Ana, Philipp, Mirna, Neto, Jorge Vaz Pinto, Escovar, Eugenio, Vasconcelos, Yuri, Filho, Jair Schimidt, Silveira, Talita, Hellwig, Tania, Fraga, Christina

“…Introduction:The management of relapsed or refractory chronic lymphocytic leukemia (r/r CLL) has undergone profound changes due to a better understanding of…”
Get full text

The Prevalence of Anemia in Rio Grande Do Sul, Brazil: Is Iron Deficiency the Silent Burden Hidden Behind “Normal” Anemia? by Silla, Lucia, Zelmanowicz, Alice, Mito, Ingrid, Daudt, Liane, Bem, Carlos do, Alves, Marta, Lehuguer, Denise, Fridrisch, João, Bittar, Christina, Fisher, Gustavo, Fogliatto, Laura, Paz, Alessandra, Bittencourt, Rosane, Bortolini, Gisele, Brouwers, Larissa, Shilling, Marco, Michalowski, Mariana, Hellwig, Tania

“…We ran a study on the prevalence of anemia in the state of Rio Grande do Sul (RS), southern Brazil. RS is in a sub-tropical Latin American area, near Uruguay…”
Get full text

South Brazilian Chronic Myeloid Leukemia (CML) Profile Patients: How We Treat and Our Results by Fogliatto, Laura, Capra, Marcelo, Schaan, Mariza, Fernandes, Mario Sergio, Pereira, Waldir, Pereira, Dalnei, Coser, Virginia, Hellwig, Tania, Nachtigal, Gilca, Zago, Aletea, Schilling, Marco, Pereira, Denise, Nene, Moema, Wisenstein, Sabrina, Lorandi, Roque, Eickhof, Cheila, Lenz, Victor Hugo, Zardo, Adriana, Wink, Adriana, Tagliari, Luciana, Guterrez, Inez, Dellacosta, Lisandra, Vanelli, Tito, Mito, Ingrid, Silla, Lucia

“…CML is a well characterized disease with a known chromosomal abnormality. The inhibition of BCR-ABL protein tyrose kinase activity represented an advance in…”
Get full text

Chronic Myeloid Leukemia (CML) Treatment in Brazil: Results of the Rio Grande do Sul Cooperative Group for Treatment of CML by Fogliatto, Laura M., Guterres, Ines, Capra, Marcelo Z., Fernandes, Mario S., Schaan, Marisa, Hellwig, Tania, Zago, Aletea, Schilling, Marco, Almeida, Denise, Wisinteiner, Sabrina, Lorandi, Roque, Winck, Adriana, Zardo, Adriana, Silla, Lucia M.R.

“…Background: Imatinib mesylate (Glivec,Novartis), an inhibitor of Bcr-abl tyrosine kinase, is currently being used in the treatment of CML with hematological,…”
Get full text